Assessing potential of psilocybin for depressive disorders
Expert Opinion on Investigational Drugs October 3, 2023 Zofia Kozak, Matthew W Johnson, Scott T Aaronson 10 citations
Patients with treatment-resistant depression may be the most suitable candidates for psilocybin treatment when weighing known risks and benefits against existing standards of care. Much remains unknown about the risks of psilocybin treatment.